Another group showed that TRIM26 expression was increased in human bladder cancer tissues and cell lines, and knocking down TRIM26 significantly inhibited the proliferation, migration, and invasion of bladder cancer cells through the Akt/GSK3β/β-catenin pathway (Xie et al., 2021). Here, GSK3B is linked to urinary bladder cancer.